Dosimetric effect of multi-leaf collimator angle change on the left-sided breast hypofractionated radiotherapy with simultaneous integrated boost

This study aimed to evaluate the effects of multi-leaf collimator angle change on the dosimetric parameters of the medial, central, and lateral tumor bed boost in hypofractionated left whole-breast irradiation with dynamic multi-leaf collimator technology. Sixty patients with early breast cancer fol...

Full description

Bibliographic Details
Published in:	Fushe yanjiu yu fushe gongyi xuebao
Main Authors:	CHEN Che, CHEN Rui, LU Zhijiang, LUO Dehong
Format:	Article
Language:	Chinese
Published:	Science Press 2023-08-01
Subjects:	breast cancer multi-leaf collimator hypofractionated radiotherapy tumor bed location dosimetry
Online Access:	http://www.fs.sinap.ac.cn/thesisDetails#10.11889/j.1000-3436.2022-0141&lang=zh

Similar Items

Dosimetric Effect Resulting From the Collimator Angle, the Isocenter Move, and the Gantry Angle Errors
by: YASSINE OULHOUQ, et al.
Published: (2019-09-01)

Predicting Erectile Dysfunction after Highly Conformal, Hypofractionated Radiotherapy to the Prostate
by: Kevin Martell, et al.
Published: (2023-05-01)

A Biological-Driven Approach to Explore Dose-Escalated Ultra-Hypofractionation in Breast Cancer Radiotherapy
by: Marco Calvaruso, et al.
Published: (2025-09-01)

Dosimetry and evaluating the effect of treatment parameters on the leakage of multi leaf collimators in ONCOR linear accelerators
by: Keyvan Jabbari, et al.
Published: (2016-01-01)

Design and dosimetric characterization of a transportable proton minibeam collimation system
by: Mabroor Ahmed, et al.
Published: (2024-12-01)

Comparison of simultaneous integrated tumor bed boost and sequential boost during hypofractionated whole-breast irradiation after breast-conserving surgery
by: Dan-Qiong Wang, et al.
Published: (2025-07-01)

Efficacy and Safety of Hypofractionated Radiotherapy With a Simultaneous Integrated Boost and With a Sequential Boost After Breast‐Conserving Surgery
by: Na Li, et al.
Published: (2025-03-01)

Acute toxicity outcomes in Egyptian early-stage breast cancer: ultra-hypofractionated versus hypofractionated radiotherapy
by: Ahmed Magdy, et al.
Published: (2025-05-01)

Long-Term Results of Postoperative Hypofractionated Accelerated Breast and Lymph Node Radiotherapy (HypoAR) with Hypofractionated Boost
by: Ioannis M. Koukourakis, et al.
Published: (2021-09-01)

Hypofractionated radiotherapy with simultaneous integrated boost for localized prostate cancer patients: effects on immune system and prediction of toxicity
by: Fiorella D’Auria, et al.
Published: (2024-10-01)

Acute skin toxicity of ultra-hypofractionated whole breast radiotherapy with simultaneous integrated boost for early breast cancer
by: Angel Montero, et al.
Published: (2023-07-01)

Efficacy and Toxicity of Hypofractionated Palliative Radiotherapy for Breast Cancer Patients with Skin Invasion
by: Talha Maqsood, et al.
Published: (2023-08-01)

A Study on Dosimetric Outcomes and Acute Toxicity of Post Mastectomy Adjuvant Hypofractionated Radiotherapy for Breast Cancer
by: Shivaprasad Deshmukh, et al.
Published: (2016-07-01)

Adaptive ultra‐hypofractionated whole‐pelvic radiotherapy in high‐risk and very high‐risk prostate cancer on 1.5‐Tesla MR‐Linac: Estimated delivered dose and early toxicity results
by: Linrui Gao, et al.
Published: (2024-03-01)

Hypofractionated Radiotherapy for Hematologic Malignancies during the COVID-19 Pandemic and Beyond
by: Febin Antony, et al.
Published: (2024-01-01)

A Hypofractionated Radiotherapy Schedule with a Simultaneous Integrated Boost for Breast Cancer: Outcomes including Late Toxicity and Health Quality
by: Zuleyha Akgun, et al.
Published: (2023-03-01)

Weekly ultra-hypofractionated radiotherapy in localised prostate cancer
by: Nora Sundahl, et al.
Published: (2024-07-01)

Dosimetric Comparison of Ultra-Hypofractionated and Conventionally Fractionated Radiation Therapy Boosts for Patients with High-Risk Prostate Cancer
by: Tomasz Piotrowski, et al.
Published: (2022-03-01)

Cost Minimization Analysis of Hypofractionated Radiotherapy
by: Hannah L. Yaremko, et al.
Published: (2021-01-01)

Ninety-degree angled collimator: a dosimetric study related to dynamic intensity-modulated radiotherapy in patients with endometrial carcinoma
by: Alparslan Serarslan, et al.
Published: (2023-06-01)

Hypofractionation and Concomitant Boost in Ductal Carcinoma In Situ (DCIS): Analysis of a Prospective Case Series with Long-Term Follow-Up
by: Domenico Cante, et al.
Published: (2022-06-01)

Ultra-hypofractionated radiotherapy with focal boost for high-risk localized prostate cancer (HYPO-RT-PC-boost): in silico evaluation with histological reference
by: Erik Nilsson, et al.
Published: (2025-10-01)

Hypofractionated Palliative Radiotherapy for Relapsed and Refractory High-Risk Neuroblastoma
by: Ellery Koelker-Wolfe, et al.
Published: (2025-02-01)

Hypofractionated versus standard fractionation radiotherapy for merkel cell carcinoma
by: Lorein Gonzalez, et al.
Published: (2024-10-01)

First experimental demonstration of magnetic resonance-guided multileaf collimator tracking for (ultra-)hypofractionated prostate radiotherapy
by: Prescilla Uijtewaal, et al.
Published: (2025-10-01)

Acute toxicity patterns and their management after moderate and ultra- hypofractionated radiotherapy for prostate cancer: A prospective cohort study
by: F. Sinzabakira, et al.
Published: (2024-09-01)

Target coverage and organs at risk dose in hypofractionated salvage radiotherapy after prostatectomy
by: Floor H.E. Staal, et al.
Published: (2024-07-01)

Design and research of an improved radiosurgical collimator
by: ZHOU Yun, et al.
Published: (2023-06-01)

The Potential of Hypofractionated Radiotherapy: A Revolutionary Treatment for Anorectal Malignant Melanomas
by: Vandana Thakur, et al.
Published: (2025-01-01)

Combinatorial hypofractionated radiotherapy and pembrolizumab in anaplastic thyroid cancer
by: Janice Ser Huey Tan, et al.
Published: (2024-02-01)

Use of hypofractionated radiotherapy regimens after organ-sparing surgery for Stages I–IIA breast cancers
by: Yu. V. Efimkina, et al.
Published: (2014-08-01)

Hypofractionated stereotactic radiotherapy using coplanar VMAT for single small brain metastasis: dosimetric analysis and clinical outcomes
by: Jialu Lai, et al.
Published: (2025-02-01)

Development of a diverging collimator for environmental radiation monitoring in the industrial fields
by: Dong-Hee Han, et al.
Published: (2022-12-01)

Gamma Camera Imaging with Rotating Multi-Pinhole Collimator. A Monte Carlo Feasibility Study
by: Victor Ilisie, et al.
Published: (2021-05-01)

Hypofractionated Post-Prostatectomy Radiotherapy in 16 Fractions: A Single-Institution Outcome
by: Pavol Dubinsky, et al.
Published: (2023-07-01)

Hypofractionated radiotherapy regimens after organ-sparing surgery for stages I–IIa breast cancer
by: Yu. V. Efimkina, et al.
Published: (2014-08-01)

Hypofractionated radiotherapy for refractory or relapsed aggressive B-cell lymphoma in the rituximab era
by: Cheng Huang, et al.
Published: (2024-01-01)

Extreme Hypofractionation with SBRT in Localized Prostate Cancer
by: Maria Antonia Gómez-Aparicio, et al.
Published: (2021-08-01)

Effect of hypofractionated radiotherapy on lung functions in breast cancer patients
by: Enass A.A. Rezk, et al.
Published: (2023-01-01)

An Extended Hypofractionated Palliative Radiotherapy Regimen for Head and Neck Carcinomas
by: Michael Laursen, et al.
Published: (2018-06-01)